Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth()

Usp9x has emerged as a potential therapeutic target in some hematologic malignancies and a broad range of solid tumors including brain, breast, and prostate. To examine Usp9x tumorigenicity and consequence of Usp9x inhibition in human pancreatic tumor models, we carried out gain- and loss-of-functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Anupama, Dziubinski, Michele, Di Magliano, Marina Pasca, Simeone, Diane M., Owens, Scott, Thomas, Dafydd, Peterson, Luke, Potu, Harish, Talpaz, Moshe, Donato, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735260/
https://www.ncbi.nlm.nih.gov/pubmed/29248719
http://dx.doi.org/10.1016/j.neo.2017.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735260/
https://www.ncbi.nlm.nih.gov/pubmed/29248719
http://dx.doi.org/10.1016/j.neo.2017.11.007

Ejemplares similares